AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT00574951 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

23

Enrollment

NETWORK

Sponsor class

Stopped Study was stopped for severe toxicity causing concern for patients

Conditions

Fallopian Tube Cancer
Ovarian Cancer
Primary Peritoneal Cavity Cancer

Interventions

DRUG: motesanib diphosphate

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]